CAS No. |
2082743-96-0 |
中文名称 |
2-氨基-9-((2R,5R,7R,8S,10R,12aR,14R,15S,15aR,16R)-14-(6-氨基-9H-嘌呤-9-基)-15,16-二氟-2,10-二巯基-2,10-二氧代-八氢-12H-5,8-甲桥-呋喃并[3,2-l][1,3,6,9,11]五氧杂[2,10]二磷杂环十四烯-7-基)-1,9-二氢-6H-嘌呤-6-酮 |
英文名称 |
2-Amino-9-((2R,5R,7R,8S,10R,12aR,14R,15S,15aR,16R)-14-(6-amino-9H-purin-9-yl)-15,16-difluoro-2,10-dimercapto-2,10-dioxidooctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11]pentaoxa[2,10]diphosphacyclotetradecin-7-yl)-1,9-dihydro-6H-purin-6-one |
别名 |
Guanosine, [P(R)]-2'-deoxy-2'-fluoro-5'-O-[(R)-hydroxymercaptophosphinyl]-P-thio-β-D-arabino-adenylyl-(3'→5')-3'-deoxy-3'-fluoro-, cyclic nucleotide;MK-1454;Ulevostinag;Ulevostinag (MK-1454);(1S,3R,6R,8R,9S,10R,12R,15R,17R)-17-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-8-(6-amino-9H-purin-9-yl)-9,18-difluoro-3,12-disulfanyl-2,4,7,11,13,16-hexaoxa-3λ?,12λ?-diphosphatricyclo[13.2.1.0?,1?]octadecane-3,12-dione |
标准英文名 |
2-Amino-9-((2R,5R,7R,8S,10R,12aR,14R,15S,15aR,16R)-14-(6-amino-9H-purin-9-yl)-15,16-difluoro-2,10-dimercapto-2,10-dioxidooctahydro-12H-5,8-methanofuro[3,2-l][1,3,6,9,11]pentaoxa[2,10]diphosphacyclotetradecin-7-yl)-1,9-dihydro-6H-purin-6-one |
分子式 |
C20H22F2N10O9P2S2 |
分子量 |
710.53
|
精确分子量 |
710.05
|
SMILES |
NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3CO[P@@](=O)(S)O[C@H]4[C@H](F)[C@H](N5C=NC6=C(N)N=CN=C65)O[C@@H]4CO[P@@](=O)(S)O[C@@H]2[C@@H]3F)C(=O)N1 |
标准SMILES |
NC1N=CN=C2C=1N=CN2[C@@H]1O[C@@H]2CO[P@@](=O)(S)O[C@H]3[C@@H](O[C@H](CO[P@@](=O)(S)O[C@H]2[C@@H]1F)[C@H]3F)N1C=NC2=C1N=C(N)NC2=O |
用途 |
Ulevostinag (MK-1454) is a potent cyclic dinucleotide agonist of stimulator of interferon genes (STING) and acts via intratumoral targeting of the STING protein; it is used in research related to immuno-oncology and cancer-associated diseases. |
InChIKey |
YSUIQYOGTINQIN-CLMXYZJCSA-N |